| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |